<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.nature.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.nature.com/npp/current_issue/rss">
<title>Neuropsychopharmacology - Issue - nature.com science feeds</title>
<description>Neuropsychopharmacology, the official publication of the American College of Neuropsychopharmacology, publishing the highest quality original research and advancing our understanding of the brain and behavior.</description>
<link>http://www.nature.com/npp/current_issue/</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights> Copyright
                    ©  Nature Publishing Group</dc:rights>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:issn>0893-133X</prism:issn>
<prism:copyright> Copyright
                    ©  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/npp.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.156" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.136" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.152" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.99" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.100" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.125" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.103" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.92" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.94" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.95" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.101" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.105" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.112" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.114" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.118" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.124" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.127" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2008.203" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.13" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.38" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.59" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.61" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.63" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.76" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/npp.2009.157" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.nature.com/npp/rss/current" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /></channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/npp.gif">
<title>Neuropsychopharmacology</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/npp.gif</url>
<link>http://www.nature.com/npp/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.156">
<title>Synergistic Interactions between Histone Deacetylase Inhibitors and Drugs of Abuse</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/hYeBY_DsOoM/npp.2009.156</link>
<content:encoded><![CDATA[
            
<p>
<b>Synergistic Interactions between Histone Deacetylase Inhibitors and Drugs of Abuse</b>
</p>
<p>Neuropsychopharmacology 34,
                2619 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.156">doi:10.1038/npp.2009.156</a>
</p>
<p>Authors: Megumi Adachi
                    &amp; Lisa M Monteggia</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/hYeBY_DsOoM" height="1" width="1"/>]]></content:encoded>
<dc:title>Synergistic Interactions between Histone Deacetylase Inhibitors and Drugs of Abuse</dc:title>
<dc:creator>Megumi Adachi</dc:creator>
<dc:creator>Lisa M Monteggia</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.156</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2619 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>September 30, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.156</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.156</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2619</prism:startingPage>
<prism:endingPage>2620</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.156</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.136">
<title>A Potential Role for Oxytocin in the Intergenerational Transmission of Secure Attachment</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/paZUe5ZjUig/npp.2009.136</link>
<content:encoded><![CDATA[
            
<p>
<b>A Potential Role for Oxytocin in the Intergenerational Transmission of Secure Attachment</b>
</p>
<p>Neuropsychopharmacology 34,
                2621 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.136">doi:10.1038/npp.2009.136</a>
</p>
<p>Author: James K Rilling</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/paZUe5ZjUig" height="1" width="1"/>]]></content:encoded>
<dc:title>A Potential Role for Oxytocin in the Intergenerational Transmission of Secure Attachment</dc:title>
<dc:creator>James K Rilling</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.136</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2621 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>September 2, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.136</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.136</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2621</prism:startingPage>
<prism:endingPage>2622</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.136</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.152">
<title>The Importance of Animal Models of Decision Making, Gambling, and Related Behaviors: Implications for Translational Research in Addiction</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/PzFZONnJIhM/npp.2009.152</link>
<content:encoded><![CDATA[
            
<p>
<b>The Importance of Animal Models of Decision Making, Gambling, and Related Behaviors: Implications for Translational Research in Addiction</b>
</p>
<p>Neuropsychopharmacology 34,
                2623 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.152">doi:10.1038/npp.2009.152</a>
</p>
<p>Author: Marc N Potenza</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/PzFZONnJIhM" height="1" width="1"/>]]></content:encoded>
<dc:title>The Importance of Animal Models of Decision Making, Gambling, and Related Behaviors: Implications for Translational Research in Addiction</dc:title>
<dc:creator>Marc N Potenza</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.152</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2623 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.152</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.152</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2623</prism:startingPage>
<prism:endingPage>2624</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.152</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.99">
<title>DSM-IV Depression with Atypical Features: Is It Valid?</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/Nauu7HYAXKc/npp.2009.99</link>
<content:encoded><![CDATA[
            
<p>
<b>DSM-IV Depression with Atypical Features: Is It Valid&#63;</b>
</p>
<p>Neuropsychopharmacology 34,
                2625 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.99">doi:10.1038/npp.2009.99</a>
</p>
<p>Authors: Jonathan W Stewart, Patrick J McGrath, Frederic M Quitkin
                    &amp; Donald F Klein</p>
<p>Keywords: atypical depression, validity, nonmelancholic depression, DSM-IV specifiers</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/Nauu7HYAXKc" height="1" width="1"/>]]></content:encoded>
<dc:title>DSM-IV Depression with Atypical Features: Is It Valid?</dc:title>
<dc:creator>Jonathan W Stewart</dc:creator>
<dc:creator>Patrick J McGrath</dc:creator>
<dc:creator>Frederic M Quitkin</dc:creator>
<dc:creator>Donald F Klein</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.99</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2625 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>September 2, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.99</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.99</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2625</prism:startingPage>
<prism:endingPage>2632</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.99</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.100">
<title>Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/Xer8S1T1JpM/npp.2009.100</link>
<content:encoded><![CDATA[
            
<p>
<b>Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria</b>
</p>
<p>Neuropsychopharmacology 34,
                2633 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.100">doi:10.1038/npp.2009.100</a>
</p>
<p>Author: Michael E Thase</p>
<p>Keywords: DSM-IV, atypical depression, MAOIs, mood reactivity, reverse neurovegetative features</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/Xer8S1T1JpM" height="1" width="1"/>]]></content:encoded>
<dc:title>Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria</dc:title>
<dc:creator>Michael E Thase</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.100</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2633 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>September 9, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.100</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.100</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2633</prism:startingPage>
<prism:endingPage>2641</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.100</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.125">
<title>Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/upU8KUX4ngU/npp.2009.125</link>
<content:encoded><![CDATA[
            
<p>
<b>Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition</b>
</p>
<p>Neuropsychopharmacology 34,
                2642 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.125">doi:10.1038/npp.2009.125</a>
</p>
<p>Authors: Carles Sanchis-Segura, Jose P Lopez-Atalaya
                    &amp; Angel Barco</p>
<p>Keywords: addiction, neuroplasticity, histone modification, sensitization, morphine, gene expression</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/upU8KUX4ngU" height="1" width="1"/>]]></content:encoded>
<dc:title>Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition</dc:title>
<dc:creator>Carles Sanchis-Segura</dc:creator>
<dc:creator>Jose P Lopez-Atalaya</dc:creator>
<dc:creator>Angel Barco</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.125</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2642 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>September 2, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.125</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.125</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2642</prism:startingPage>
<prism:endingPage>2654</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.125</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.103">
<title>Adult Attachment Predicts Maternal Brain and Oxytocin Response to Infant Cues</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/7MhCqOOF-zI/npp.2009.103</link>
<content:encoded><![CDATA[
            
<p>
<b>Adult Attachment Predicts Maternal Brain and Oxytocin Response to Infant Cues</b>
</p>
<p>Neuropsychopharmacology 34,
                2655 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.103">doi:10.1038/npp.2009.103</a>
</p>
<p>Authors: Lane Strathearn, Peter Fonagy, Janet Amico
                    &amp; P Read Montague</p>
<p>Keywords: attachment, mother&#8211;infant relations, dopamine, oxytocin, functional MRI, insula</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/7MhCqOOF-zI" height="1" width="1"/>]]></content:encoded>
<dc:title>Adult Attachment Predicts Maternal Brain and Oxytocin Response to Infant Cues</dc:title>
<dc:creator>Lane Strathearn</dc:creator>
<dc:creator>Peter Fonagy</dc:creator>
<dc:creator>Janet Amico</dc:creator>
<dc:creator>P Read Montague</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.103</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2655 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 26, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.103</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.103</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2655</prism:startingPage>
<prism:endingPage>2666</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.103</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.92">
<title>Differential Effects of Tri-Allelic 5-HTTLPR Polymorphisms in Healthy Subjects on Mood and Stress Performance After Tryptophan Challenge</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/5P5Y1cXyW_Y/npp.2009.92</link>
<content:encoded><![CDATA[
            
<p>
<b>Differential Effects of Tri-Allelic 5-HTTLPR Polymorphisms in Healthy Subjects on Mood and Stress Performance After Tryptophan Challenge</b>
</p>
<p>Neuropsychopharmacology 34,
                2667 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.92">doi:10.1038/npp.2009.92</a>
</p>
<p>Authors: C Rob Markus
                    &amp; Christine Firk</p>
<p>Keywords: serotonin, vulnerability, 5-HTTLPR, stress, tryptophan</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/5P5Y1cXyW_Y" height="1" width="1"/>]]></content:encoded>
<dc:title>Differential Effects of Tri-Allelic 5-HTTLPR Polymorphisms in Healthy Subjects on Mood and Stress Performance After Tryptophan Challenge</dc:title>
<dc:creator>C Rob Markus</dc:creator>
<dc:creator>Christine Firk</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.92</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2667 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 12, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.92</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.92</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2667</prism:startingPage>
<prism:endingPage>2674</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.92</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.94">
<title>Modulation of Limbic Circuitry Predicts Treatment Response to Antipsychotic Medication: A Functional Imaging Study in Schizophrenia</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/F1M44_AEh-g/npp.2009.94</link>
<content:encoded><![CDATA[
            
<p>
<b>Modulation of Limbic Circuitry Predicts Treatment Response to Antipsychotic Medication: A Functional Imaging Study in Schizophrenia</b>
</p>
<p>Neuropsychopharmacology 34,
                2675 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.94">doi:10.1038/npp.2009.94</a>
</p>
<p>Authors: Adrienne C Lahti, Martin A Weiler, Henry H Holcomb, Carol A Tamminga
                    &amp; Karen L Cropsey</p>
<p>Keywords: schizophrenia, PET, rCBF, haloperidol, olanzapine</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/F1M44_AEh-g" height="1" width="1"/>]]></content:encoded>
<dc:title>Modulation of Limbic Circuitry Predicts Treatment Response to Antipsychotic Medication: A Functional Imaging Study in Schizophrenia</dc:title>
<dc:creator>Adrienne C Lahti</dc:creator>
<dc:creator>Martin A Weiler</dc:creator>
<dc:creator>Henry H Holcomb</dc:creator>
<dc:creator>Carol A Tamminga</dc:creator>
<dc:creator>Karen L Cropsey</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.94</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2675 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 12, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.94</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.94</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2675</prism:startingPage>
<prism:endingPage>2690</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.94</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.95">
<title>Impairments of Probabilistic Response Reversal and Passive Avoidance Following Catecholamine Depletion</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/9KAkEMJCBtg/npp.2009.95</link>
<content:encoded><![CDATA[
            
<p>
<b>Impairments of Probabilistic Response Reversal and Passive Avoidance Following Catecholamine Depletion</b>
</p>
<p>Neuropsychopharmacology 34,
                2691 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.95">doi:10.1038/npp.2009.95</a>
</p>
<p>Authors: Gregor Hasler, Krystal Mondillo, Wayne C Drevets
                    &amp; James R Blair</p>
<p>Keywords: dopamine, norepinephrine, reinforcement learning, remitted major depressive disorder, attention, stroop</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/9KAkEMJCBtg" height="1" width="1"/>]]></content:encoded>
<dc:title>Impairments of Probabilistic Response Reversal and Passive Avoidance Following Catecholamine Depletion</dc:title>
<dc:creator>Gregor Hasler</dc:creator>
<dc:creator>Krystal Mondillo</dc:creator>
<dc:creator>Wayne C Drevets</dc:creator>
<dc:creator>James R Blair</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.95</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2691 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 12, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.95</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.95</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2691</prism:startingPage>
<prism:endingPage>2698</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.95</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.101">
<title>Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/_pkE8pVfN1k/npp.2009.101</link>
<content:encoded><![CDATA[
            
<p>
<b>Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala</b>
</p>
<p>Neuropsychopharmacology 34,
                2699 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.101">doi:10.1038/npp.2009.101</a>
</p>
<p>Authors: Sachin Patel, Philip J Kingsley, Ken Mackie, Lawrence J Marnett
                    &amp; Danny G Winder</p>
<p>Keywords: endocannabinoid, CB1 receptor, anxiety, depression, marijuana, diacylglycerol lipase</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/_pkE8pVfN1k" height="1" width="1"/>]]></content:encoded>
<dc:title>Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala</dc:title>
<dc:creator>Sachin Patel</dc:creator>
<dc:creator>Philip J Kingsley</dc:creator>
<dc:creator>Ken Mackie</dc:creator>
<dc:creator>Lawrence J Marnett</dc:creator>
<dc:creator>Danny G Winder</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.101</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2699 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 12, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.101</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.101</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2699</prism:startingPage>
<prism:endingPage>2709</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.101</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.105">
<title>Disruption of Mesolimbic Regulation of Prefrontal Cholinergic Transmission in an Animal Model of Schizophrenia and Normalization by Chronic Clozapine Treatment</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/7mx_GGVlLC8/npp.2009.105</link>
<content:encoded><![CDATA[
            
<p>
<b>Disruption of Mesolimbic Regulation of Prefrontal Cholinergic Transmission in an Animal Model of Schizophrenia and Normalization by Chronic Clozapine Treatment</b>
</p>
<p>Neuropsychopharmacology 34,
                2710 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.105">doi:10.1038/npp.2009.105</a>
</p>
<p>Authors: Kathleen S Alexander, Julie M Brooks, Martin Sarter
                    &amp; John P Bruno</p>
<p>Keywords: acetylcholine, hippocampus, prefrontal cortex, nucleus accumbens, schizophrenia, clozapine</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/7mx_GGVlLC8" height="1" width="1"/>]]></content:encoded>
<dc:title>Disruption of Mesolimbic Regulation of Prefrontal Cholinergic Transmission in an Animal Model of Schizophrenia and Normalization by Chronic Clozapine Treatment</dc:title>
<dc:creator>Kathleen S Alexander</dc:creator>
<dc:creator>Julie M Brooks</dc:creator>
<dc:creator>Martin Sarter</dc:creator>
<dc:creator>John P Bruno</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.105</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2710 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 19, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.105</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.105</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2710</prism:startingPage>
<prism:endingPage>2720</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.105</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.112">
<title>Contribution of Hypothalamic–Pituitary–Adrenal Activity and Environmental Stress to Vulnerability for Smoking in Adolescents</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/PLhfI9hG4bs/npp.2009.112</link>
<content:encoded><![CDATA[
            
<p>
<b>Contribution of Hypothalamic&#8211;Pituitary&#8211;Adrenal Activity and Environmental Stress to Vulnerability for Smoking in Adolescents</b>
</p>
<p>Neuropsychopharmacology 34,
                2721 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.112">doi:10.1038/npp.2009.112</a>
</p>
<p>Authors: Uma Rao, Constance L Hammen, Edythe D London
                    &amp; Russell E Poland</p>
<p>Keywords: adolescents, depression, HPA axis, smoking, stress, vulnerability</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/PLhfI9hG4bs" height="1" width="1"/>]]></content:encoded>
<dc:title>Contribution of Hypothalamic–Pituitary–Adrenal Activity and Environmental Stress to Vulnerability for Smoking in Adolescents</dc:title>
<dc:creator>Uma Rao</dc:creator>
<dc:creator>Constance L Hammen</dc:creator>
<dc:creator>Edythe D London</dc:creator>
<dc:creator>Russell E Poland</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.112</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2721 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 19, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.112</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.112</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2721</prism:startingPage>
<prism:endingPage>2732</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.112</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.114">
<title>Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/gpCw2Diutdk/npp.2009.114</link>
<content:encoded><![CDATA[
            
<p>
<b>Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic&#8211;Pituitary&#8211;Adrenal Axis</b>
</p>
<p>Neuropsychopharmacology 34,
                2733 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.114">doi:10.1038/npp.2009.114</a>
</p>
<p>Authors: Matthew N Hill, Ryan J McLaughlin, Anna C Morrish, Victor Viau, Stan B Floresco, Cecilia J Hillard
                    &amp; Boris B Gorzalka</p>
<p>Keywords: stress, amygdala, HPA axis, anxiety, cannabinoid, corticosterone</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/gpCw2Diutdk" height="1" width="1"/>]]></content:encoded>
<dc:title>Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis</dc:title>
<dc:creator>Matthew N Hill</dc:creator>
<dc:creator>Ryan J McLaughlin</dc:creator>
<dc:creator>Anna C Morrish</dc:creator>
<dc:creator>Victor Viau</dc:creator>
<dc:creator>Stan B Floresco</dc:creator>
<dc:creator>Cecilia J Hillard</dc:creator>
<dc:creator>Boris B Gorzalka</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.114</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2733 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 26, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.114</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.114</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2733</prism:startingPage>
<prism:endingPage>2745</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.114</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.118">
<title>Behavioral Disinhibition and Reduced Anxiety-like Behaviors in Monoamine Oxidase B-Deficient Mice</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/VJxxsfRrx5Y/npp.2009.118</link>
<content:encoded><![CDATA[
            
<p>
<b>Behavioral Disinhibition and Reduced Anxiety-like Behaviors in Monoamine Oxidase B-Deficient Mice</b>
</p>
<p>Neuropsychopharmacology 34,
                2746 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.118">doi:10.1038/npp.2009.118</a>
</p>
<p>Authors: Marco Bortolato, Sean C Godar, Shieva Davarian, Kevin Chen
                    &amp; Jean C Shih</p>
<p>Keywords: monoamine oxidase B, mice, behavioral disinhibition, anxiety, phenylethylamine</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/VJxxsfRrx5Y" height="1" width="1"/>]]></content:encoded>
<dc:title>Behavioral Disinhibition and Reduced Anxiety-like Behaviors in Monoamine Oxidase B-Deficient Mice</dc:title>
<dc:creator>Marco Bortolato</dc:creator>
<dc:creator>Sean C Godar</dc:creator>
<dc:creator>Shieva Davarian</dc:creator>
<dc:creator>Kevin Chen</dc:creator>
<dc:creator>Jean C Shih</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.118</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2746 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>August 26, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.118</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.118</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2746</prism:startingPage>
<prism:endingPage>2757</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.118</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.124">
<title>Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson's Disease?</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/_7BHY7qQAto/npp.2009.124</link>
<content:encoded><![CDATA[
            
<p>
<b>Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson's Disease&#63;</b>
</p>
<p>Neuropsychopharmacology 34,
                2758 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.124">doi:10.1038/npp.2009.124</a>
</p>
<p>Authors: Thilo van Eimeren, B&#233;n&#233;dicte Ballanger, Giovanna Pellecchia, Janis M Miyasaki, Anthony E Lang
                    &amp; Antonio P Strafella</p>
<p>Keywords: fMRI, impulse control disorder, dopamine agonist, reward, addiction, reinforcement</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/_7BHY7qQAto" height="1" width="1"/>]]></content:encoded>
<dc:title>Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson's Disease?</dc:title>
<dc:creator>Thilo van Eimeren</dc:creator>
<dc:creator>Bénédicte Ballanger</dc:creator>
<dc:creator>Giovanna Pellecchia</dc:creator>
<dc:creator>Janis M Miyasaki</dc:creator>
<dc:creator>Anthony E Lang</dc:creator>
<dc:creator>Antonio P Strafella</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.124</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2758 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>September 9, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.124</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.124</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2758</prism:startingPage>
<prism:endingPage>2766</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.124</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.127">
<title>Environmental Enrichment Reduces Cocaine Seeking and Reinstatement Induced by Cues and Stress but Not by Cocaine</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/bbUKP6fQOQQ/npp.2009.127</link>
<content:encoded><![CDATA[
            
<p>
<b>Environmental Enrichment Reduces Cocaine Seeking and Reinstatement Induced by Cues and Stress but Not by Cocaine</b>
</p>
<p>Neuropsychopharmacology 34,
                2767 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.127">doi:10.1038/npp.2009.127</a>
</p>
<p>Authors: Claudia Chauvet, Virginie Lardeux, Steven R Goldberg, Mohamed Jaber
                    &amp; Marcello Solinas</p>
<p>Keywords: environment, addiction, stress, relapse, protracted abstinence, behavioral therapy</p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/bbUKP6fQOQQ" height="1" width="1"/>]]></content:encoded>
<dc:title>Environmental Enrichment Reduces Cocaine Seeking and Reinstatement Induced by Cues and Stress but Not by Cocaine</dc:title>
<dc:creator>Claudia Chauvet</dc:creator>
<dc:creator>Virginie Lardeux</dc:creator>
<dc:creator>Steven R Goldberg</dc:creator>
<dc:creator>Mohamed Jaber</dc:creator>
<dc:creator>Marcello Solinas</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.127</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2767 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:publicationDate>September 9, 2009</prism:publicationDate>
<prism:doi>10.1038/npp.2009.127</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.127</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2767</prism:startingPage>
<prism:endingPage>2778</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.127</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2008.203">
<title>Billy R Martin</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/dvnhZ7KUfKU/npp.2008.203</link>
<content:encoded><![CDATA[
            
<p>
<b>Billy R Martin</b>
</p>
<p>Neuropsychopharmacology 34,
                2779 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2008.203">doi:10.1038/npp.2008.203</a>
</p>
<p>Author: William L Dewey</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/dvnhZ7KUfKU" height="1" width="1"/>]]></content:encoded>
<dc:title>Billy R Martin</dc:title>
<dc:creator>William L Dewey</dc:creator>
<dc:identifier>doi:10.1038/npp.2008.203</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2779 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2008.203</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2008.203</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2779</prism:startingPage>
<prism:endingPage>2779</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2008.203</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.13">
<title>Albert Kurland</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/LK5A80mUW0Q/npp.2009.13</link>
<content:encoded><![CDATA[
            
<p>
<b>Albert Kurland</b>
</p>
<p>Neuropsychopharmacology 34,
                2780 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.13">doi:10.1038/npp.2009.13</a>
</p>
<p>Author: Bruce T Taylor</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/LK5A80mUW0Q" height="1" width="1"/>]]></content:encoded>
<dc:title>Albert Kurland</dc:title>
<dc:creator>Bruce T Taylor</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.13</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2780 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.13</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.13</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2780</prism:startingPage>
<prism:endingPage>2780</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.13</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.38">
<title>Louis A Gottschalk</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/Hd2gf5LVe_s/npp.2009.38</link>
<content:encoded><![CDATA[
            
<p>
<b>Louis A Gottschalk</b>
</p>
<p>Neuropsychopharmacology 34,
                2781 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.38">doi:10.1038/npp.2009.38</a>
</p>
<p>Author: William E Bunney</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/Hd2gf5LVe_s" height="1" width="1"/>]]></content:encoded>
<dc:title>Louis A Gottschalk</dc:title>
<dc:creator>William E Bunney</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.38</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2781 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.38</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.38</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2781</prism:startingPage>
<prism:endingPage>2781</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.38</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.59">
<title>Gary Tollefson</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/7778HrYeSyw/npp.2009.59</link>
<content:encoded><![CDATA[
            
<p>
<b>Gary Tollefson</b>
</p>
<p>Neuropsychopharmacology 34,
                2782 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.59">doi:10.1038/npp.2009.59</a>
</p>
<p>Author: Steven M Paul</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/7778HrYeSyw" height="1" width="1"/>]]></content:encoded>
<dc:title>Gary Tollefson</dc:title>
<dc:creator>Steven M Paul</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.59</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2782 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.59</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.59</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2782</prism:startingPage>
<prism:endingPage>2782</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.59</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.61">
<title>Norman Weiner</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/nqoUKDGRn6U/npp.2009.61</link>
<content:encoded><![CDATA[
            
<p>
<b>Norman Weiner</b>
</p>
<p>Neuropsychopharmacology 34,
                2783 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.61">doi:10.1038/npp.2009.61</a>
</p>
<p>Authors: Perry B Molinoff
                    &amp; A N Richards</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/nqoUKDGRn6U" height="1" width="1"/>]]></content:encoded>
<dc:title>Norman Weiner</dc:title>
<dc:creator>Perry B Molinoff</dc:creator>
<dc:creator>A N Richards</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.61</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2783 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.61</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.61</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2783</prism:startingPage>
<prism:endingPage>2784</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.61</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.63">
<title>Sachindra Nath Pradhan</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/ZU5EckDSOOs/npp.2009.63</link>
<content:encoded><![CDATA[
            
<p>
<b>Sachindra Nath Pradhan</b>
</p>
<p>Neuropsychopharmacology 34,
                2785 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.63">doi:10.1038/npp.2009.63</a>
</p>
<p>Author: William B Lawson</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/ZU5EckDSOOs" height="1" width="1"/>]]></content:encoded>
<dc:title>Sachindra Nath Pradhan</dc:title>
<dc:creator>William B Lawson</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.63</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2785 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.63</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.63</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2785</prism:startingPage>
<prism:endingPage>2785</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.63</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.76">
<title>Wagner H Bridger</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/PotazpzpSfg/npp.2009.76</link>
<content:encoded><![CDATA[
            
<p>
<b>Wagner H Bridger</b>
</p>
<p>Neuropsychopharmacology 34,
                2786 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.76">doi:10.1038/npp.2009.76</a>
</p>
<p>Author: George M Simpson</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/PotazpzpSfg" height="1" width="1"/>]]></content:encoded>
<dc:title>Wagner H Bridger</dc:title>
<dc:creator>George M Simpson</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.76</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2786 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.76</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.76</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2786</prism:startingPage>
<prism:endingPage>2786</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.76</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/npp.2009.157">
<title>Elizabeth Young</title>
<link>http://feeds.nature.com/~r/npp/rss/current/~3/66VYp_uFOls/npp.2009.157</link>
<content:encoded><![CDATA[
            
<p>
<b>Elizabeth Young</b>
</p>
<p>Neuropsychopharmacology 34,
                2787 (December 2009). <a href="http://dx.doi.org/10.1038/npp.2009.157">doi:10.1038/npp.2009.157</a>
</p>
<p>Author: Huda Akil</p>
<p>Keywords: </p>
<img src="http://feeds.feedburner.com/~r/npp/rss/current/~4/66VYp_uFOls" height="1" width="1"/>]]></content:encoded>
<dc:title>Elizabeth Young</dc:title>
<dc:creator>Huda Akil</dc:creator>
<dc:identifier>doi:10.1038/npp.2009.157</dc:identifier>
<dc:source>Neuropsychopharmacology 34, 2787 (December 2009)</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Neuropsychopharmacology</prism:publicationName>
<prism:doi>10.1038/npp.2009.157</prism:doi>
<prism:url>http://dx.doi.org/10.1038/npp.2009.157</prism:url>
<prism:volume>34</prism:volume>
<prism:number>13</prism:number>
<prism:startingPage>2787</prism:startingPage>
<prism:endingPage>2787</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/npp.2009.157</feedburner:origLink></item>
</rdf:RDF>
